Corrected: South Africa's Life Healthcare not ruling out return to India after Max disposal

Image
Reuters
Last Updated : Sep 24 2018 | 8:15 PM IST

(Corrects paragraph seven in Sept. 20 story to show the loss of licence at Max Shalimar Bagh was temporary)

By Patricia Aruo

JOHANNESBURG (Reuters) - South African private hospital group Life Healthcare has said it is not ruling out a return to India after selling the firm's entire stake in Max Healthcare, in an effort to focus on its operations elsewhere.

The hospital group said on Wednesday it will sell its entire 49.7 percent stake in India's Max Healthcare to global investment firm KKR & Co. L.P. for 4.3 billion rand ($293 million).

"In the long-term, India is still a very exciting healthcare environment. South Africa is still a strategic focus for us and Europe, given the significant investments we have made there in recent years," Chief Executive Shrey Viranna told Reuters on Thursday.

"Max was a good investment with a strong management team but it was more about our strategy."

Max Healthcare has also been grappling with regulatory changes in India over the past year, he said.

Indian authorities proposed capping medical costs at private hospitals in the capital to help millions of people, but the plan would deal a blow to the multi-billion-dollar healthcare sector already grappling with price control policies.

In the six-months to the end of March, Max Healthcare reported a wider loss of 67 million rand compared with a loss of 12 million in 2017, negatively impacted by the increased regulatory environment and the temporary closure of Max Shalimar Bagh hospital over an alleged case of medical negligence.

Following the disposal, Life Healthcare wants to focus its attention on its core operations in South Africa, UK, Poland and Western Europe.

The company, whose local competitors include Netcare and Mediclinic has diversified geographically and has also started offering new services.

In 2016 it entered the diagnostic imaging market through the acquisition of UK-based Alliance Medical Group, which also operates in Ireland, Italy, Spain and Northern Europe.

Viranna said the group will continue to make strategic investments in its existing markets, without giving any details.

"We will absolutely look to invest for growth where it makes good financial sense for us. We will look to invest very selectively in our existing geographies as opposed to adding new ones," he added.

($1 = 0.7557 pounds)

(Editing by James Macharia)

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Sep 24 2018 | 8:06 PM IST

Next Story